After the recalls of tens of millions of bottles and packages of numerous over-the-counter meds and surgical devices; months of negative publicity about corporate behavior; various government investigations and highly publicized congressional hearings, consumers may be turning away from Johnson & Johnson (JNJ) OTC products (back stories here, here, here and here).
In the last quarter of 2010, Johnson & Johnson’s share of the $4.2 billion cough and cold market sank to about 5 percent from about 17 percent in early 2009, according to Nielsen data cited by Wells Fargo analyst Larry Biegelsen in an investor note. The J&J share of the $2.4 billion pain and arthritis market fell to just below 10 percent from just under 20 percent during the same period, while its share of the $1.4 billion gastrointestinal market slid to less than 5 percent from more than 10 percent.
Complete Story »
Brittany Snow Lauren German Cindy Crawford Mariah OBrien Uma Thurman
No comments:
Post a Comment